Glucocorticosteroids as dengue therapeutics: resolving clinical observations with a primary human macrophage model
- PMID: 23243185
- PMCID: PMC3582356
- DOI: 10.1093/cid/cis1048
Glucocorticosteroids as dengue therapeutics: resolving clinical observations with a primary human macrophage model
Figures
Comment in
-
Reply to Halstead and Sayce et al.Clin Infect Dis. 2013 Mar;56(6):903-4. doi: 10.1093/cid/cis1049. Epub 2012 Dec 14. Clin Infect Dis. 2013. PMID: 23243184 Free PMC article. No abstract available.
Comment on
-
Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial.Clin Infect Dis. 2012 Nov;55(9):1216-24. doi: 10.1093/cid/cis655. Epub 2012 Aug 3. Clin Infect Dis. 2012. PMID: 22865871 Free PMC article. Clinical Trial.
References
-
- Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011;11:532–43. - PubMed
-
- Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002;185:1213–21. - PubMed
-
- Green S, Vaughn DW, Kalayanarooj S, et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis. 1999;179:755–62. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
